Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex

Area of Science:

• Genomics
• Epigenetics
• Neuroscience

Background:

• Epigenetic clocks using DNA methylation are biomarkers of aging, widely applied to assess biological age in health and disease.
• Existing clocks show high accuracy in blood but lower precision in brain tissue, especially in older samples.
• This limitation hinders the study of brain aging phenotypes and neurodegenerative diseases.

Purpose of the Study:

• To develop a novel epigenetic clock specifically optimized for human cortex tissue.
• To enhance the accuracy of biological age estimation in the brain.
• To provide a more reliable tool for identifying brain aging phenotypes.

Main Methods:

• Generated an extensive dataset of human cortex DNA methylation data (n=1397, ages 1-108).
• Employed elastic net regression, a supervised machine learning method, to derive age predictors.
• Validated the novel cortical clock in independent cortex and whole blood datasets.

Main Results:

• Identified 347 DNA methylation sites that optimally predict age in the human cortex.
• The novel cortical clock significantly outperformed previous epigenetic clocks in brain tissue.
• Demonstrated the clock's specificity and robustness across different age groups and tissue types.

Conclusions:

• The developed cortical epigenetic clock offers superior accuracy for brain aging assessment.
• Previous associations between epigenetic age and neurodegeneration may be influenced by tissue-specific clock calibration.
• Emphasizes the importance of tissue type and age distribution in training data for epigenetic clock development and application.